Team:Freiburg

From 2013.igem.org

(Difference between revisions)
 
(38 intermediate revisions not shown)
Line 92: Line 92:
font-size:15px;
font-size:15px;
float:left;
float:left;
 +
text-align:justify;
}
}
Line 221: Line 222:
     regulation in mammalian cells.  Therefore, we engineered the recently understood and highly promising   
     regulation in mammalian cells.  Therefore, we engineered the recently understood and highly promising   
     CRISPR/Cas9 system. <br>
     CRISPR/Cas9 system. <br>
-
       The regulation is based on the RNA-guided Cas9 protein, which allows targeting of specific DNA sequences.  
+
       The regulation is based on the RNA-guided dCas9 protein, which allows specific targeting of DNA sequences.  
-
       Our toolkit comprises not only a standardized Cas9 protein,  but also different effector domains for  
+
       Our toolkit comprises not only a standardized dCas9 protein,  but also different effector domains for  
       efficient gene activation or repression.  
       efficient gene activation or repression.  
</div>  
</div>  
Line 273: Line 274:
<ul style="margin-left:160px">
<ul style="margin-left:160px">
-
<li style="margin-top: -30px; padding-bottom:10px;"><a href="https://2013.igem.org/Team:Freiburg/Project/crrna#multiple_targeting">
+
<li style="margin-top: -30px; padding-bottom:10px;"><a href="https://2013.igem.org/Team:Freiburg/Project/crrna">
   <img src="https://static.igem.org/mediawiki/2013/b/bb/Freiburg_2013_main2_Multiple_Targeting.png">
   <img src="https://static.igem.org/mediawiki/2013/b/bb/Freiburg_2013_main2_Multiple_Targeting.png">
<span> Multiple targeting </span>
<span> Multiple targeting </span>
Line 322: Line 323:
   <div id="text-box3">  
   <div id="text-box3">  
       <div id="text_gross" align="left"><a style="position:absolute; top:678px; left:60px; z-index:2" href="https://2013.igem.org/Team:Freiburg/Highlights"> Highlights </div> </a>
       <div id="text_gross" align="left"><a style="position:absolute; top:678px; left:60px; z-index:2" href="https://2013.igem.org/Team:Freiburg/Highlights"> Highlights </div> </a>
-
   <p style="position:absolute; top:720px; left:60px" > All about our <br> project on one <br> page! </p>
+
   <p style="position:absolute; top:720px; left:60px" > All about our <br> project in one <br> slide show! </p>
  <img src="https://static.igem.org/mediawiki/2013/0/0e/Freiburg_2013_main2_Highlights5.png" height="190" style="position:absolute; top:614px; left:105px; z-index:1">  
  <img src="https://static.igem.org/mediawiki/2013/0/0e/Freiburg_2013_main2_Highlights5.png" height="190" style="position:absolute; top:614px; left:105px; z-index:1">  
   </div>  
   </div>  
Line 381: Line 382:
   <div id="text-box6">  
   <div id="text-box6">  
    
    
-
      <div id="text_gross" align="left"> <a style="position:absolute; top:678px; left:910px; z-index:2" href="https://2013.igem.org/Team:Freiburg/Team2"> Team </a></div>
+
<div id="text_gross" align="left"> <a style="position:absolute; top:678px; left:910px; z-index:2" href="https://2013.igem.org/Team:Freiburg/News"> News </a></div>
-
  <img src="https://static.igem.org/mediawiki/2013/9/91/Freiburg_2013_main2_teamkachel_TEAM2.png" height="140" style="position:absolute; top:685px; left:900px; z-index:1">  
+
<p style="padding-top:10px;">
 +
Have a look at our achievements in Lyon & Boston!
 +
</p>
 +
<img src="https://static.igem.org/mediawiki/2013/5/56/Best-foundational-advance-2013-freiburg.png" height="130" style="position:absolute; top:600px; left:980px; z-index:1">  
   </div>  
   </div>  
 +
</div>
   <img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png">  
   <img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png">  
   </td>
   </td>
Line 393: Line 398:
</div>
</div>
 +
 +
<center>
 +
<!-- Start of StatCounter Code for Default Guide -->
 +
<script type="text/javascript">
 +
var sc_project=9733368;
 +
var sc_invisible=0;
 +
var sc_security="e5b3d57c";
 +
var scJsHost = (("https:" == document.location.protocol) ?
 +
"https://secure." : "http://www.");
 +
document.write("<sc"+"ript type='text/javascript' src='" +
 +
scJsHost+
 +
"statcounter.com/counter/counter.js'></"+"script>");
 +
</script>
 +
<noscript><div class="statcounter"><a title="click tracking"
 +
href="http://statcounter.com/" target="_blank"><img
 +
class="statcounter"
 +
src="http://c.statcounter.com/9733368/0/e5b3d57c/0/"
 +
alt="click tracking"></a></div></noscript>
 +
<!-- End of StatCounter Code for Default Guide -->
 +
</center>
 +
</body>
</body>
</html>
</html>

Latest revision as of 23:52, 9 April 2014


Our Team developed a universal toolkit, termed uniCAS, that enables customizable gene regulation in mammalian cells. Therefore, we engineered the recently understood and highly promising CRISPR/Cas9 system.
The regulation is based on the RNA-guided dCas9 protein, which allows specific targeting of DNA sequences. Our toolkit comprises not only a standardized dCas9 protein, but also different effector domains for efficient gene activation or repression.

All about our
project in one
slide show!

Use our Toolkit
to regulate your
genes!

Have a look at our achievements in Lyon & Boston!